These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7283413)

  • 1. Pharmacology, Safety, and efficacy of cefamandole in childhood infections.
    Thirumoorthi MC; Dajani AS; Vincent CV; Maurer MJ
    Antimicrob Agents Chemother; 1981 Jul; 20(1):21-4. PubMed ID: 7283413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cefamandole in the treatment of soft tissue and skeletal infections.
    LeFrock JL; Paparone P; Kowalsky SF; Schell RF; Jacobs RL; Wirth CR; Tillotson JR
    Drug Intell Clin Pharm; 1981 Dec; 15(12):951-7. PubMed ID: 7338190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of osteomyelitis and septic arthritis with cefamandole.
    Bernstein BM; Fass RJ
    Am J Med Sci; 1982; 284(3):2-8. PubMed ID: 7148886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of cefamandole in childhood infections.
    Paul RS; Kumar A; Worthington DC; Walton RO
    Clin Ther; 1983; 5(6):617-23. PubMed ID: 6627287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with cefamandole for treatment of serious bone and joint infections.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S119-S124. PubMed ID: 649996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory investigation of cefamandole therapy of infections in infants and children.
    Azimi PH
    J Infect Dis; 1978 May; 137 Suppl():S155-S160. PubMed ID: 349094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory investigation of cefamandole in infections of infants and children.
    Azimi PA
    Antimicrob Agents Chemother; 1978 Jun; 13(6):955-7. PubMed ID: 307939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory evaluation of cefamandole in infants and children.
    Rodriguez WJ; Ross S; Khan WN; Goldenberg R
    J Infect Dis; 1978 May; 137 Suppl():S150-S154. PubMed ID: 306402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of obstetric and gynecologic infections with cefamandole.
    Cunningham FG; Gilstrap LC; Kappus SS
    Am J Obstet Gynecol; 1979 Mar; 133(6):602-10. PubMed ID: 426015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
    Wallace RJ; Niefield SL; Waters S; Waters B; Awe RJ; Wiss K; Martin RR; Greenberg SB
    Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefamandole in the treatment of serious bone and joint diseases.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of serious skin and soft tissue infections with cefamandole.
    Glanges E; Webber CE; Crenshaw CA; Pasquet M; Barksdale L
    Scand J Infect Dis Suppl; 1980; suppl 25():69-74. PubMed ID: 7010539
    [No Abstract]   [Full Text] [Related]  

  • 13. Cefamandole nafate: an evaluation of antibacterial activity, serum levels, clinical effect, and incidence of side reactions in 58 patients.
    Ekwall E; Holmgren EB; Lundbergh P; Svanbom M; Tunevall G
    Scand J Infect Dis; 1979; 11(2):135-9. PubMed ID: 462128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.
    Nelson JD; Bucholz RW; Kusmiesz H; Shelton S
    J Pediatr Orthop; 1982 Aug; 2(3):255-62. PubMed ID: 7130382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
    Perkins RL; Fass RJ; Warner JF; Prior RB; File TM; Tight RR; Gardner WG; Ruiz DE; Slama TG
    J Infect Dis; 1978 May; 137 Suppl():S110-S118. PubMed ID: 418126
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefamandole for treatment of obstetrical and gynecological infections.
    Cunningham FG; Gilstrap LC; Kappus SS
    Scand J Infect Dis Suppl; 1980; suppl 25():75-82. PubMed ID: 7010540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M; Deamer RL; Prichard JG
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory and clinical study of cefamandole by intravenous injection in the pediatric field (author's transl)].
    Nakazawa S; Satoh H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Chikaoka H; Oka S; Hirama Y; Narita A
    Jpn J Antibiot; 1979 Nov; 32(11):1081-90. PubMed ID: 513290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental and clinical studies on cefamandole in pediatric treatment (author's transl)].
    Motohiro T; Sakata Y; Nishiyama T; Nakajima T; Imai H; Ishimoto K; Tominaga K; Yamashita F; Takeya S
    Jpn J Antibiot; 1979 Sep; 32(9):930-7. PubMed ID: 501920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.